AGIOS PHARMACEUTICALS, INC.·4

Feb 24, 4:12 PM ET

Alenson Carman 4

4 · AGIOS PHARMACEUTICALS, INC. · Filed Feb 24, 2021

Insider Transaction Report

Form 4
Period: 2021-02-22
Alenson Carman
Principal Accounting Officer
Transactions
  • Exercise/Conversion

    Common stock

    2021-02-22+6921,994 total
  • Tax Payment

    Common stock

    2021-02-221991,795 total
  • Exercise/Conversion

    Restricted stock units

    2021-02-22692691 total
    Common stock (692 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
  • [F2]The restricted stock units were granted on February 22, 2019. Beginning on February 22, 2020, the shares underlying the restricted stock units will vest in three equal annual installments.

Documents

1 file
  • 4
    wf-form4_161420111004318.xmlPrimary

    FORM 4